About the 3rd Annual Neuroscience Innovation Forum
Building on the success of our 2nd Annual NIF we are pleased to announce our 3rd Annual Neuroscience Innovation Forum for Business Development, Licensing & Investment to take place at the Marines' Memorial Club, San Francisco on the 12th of January 2020, a day before the JP Morgan meeting.
The program will cover BioPartnering for CNS, with industry keynotes and panels on AD, PD, Neuropsychiatry and Pain Management. Moreover, there are panels on innovation in NeuroTech covering banking, device, diagnostics and software.
The target audience are buy and sell side analysts from investment banks and funds and partnering executives from pharma, biotech and medtech companies. We anticipate around 300 delegates and 35+ company presentations by established listed, private and emerging companies.
There are numerous networking opportunities available via an online One-2-One meeting system with dedicated meeting facilities to make the event more transactional.
Plenary & Therapeutic Sessions will Include:
Confirmed Keynote Speeches by:
Confirmed Speakers & Chairs Include:
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business.
Presenting Companies in 2020 Forum Include:
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.
Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.
To learn more about presenting, exhibition or sponsorship opportunities, please contact:
Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia
Participating Pharmas Include:
Investors & Analysts Attending:
5AM Venture Management LLC
6 Dimensions Capital
Aisling Capital LLC
Albion Ventures LLP
Alta Global Ventures
Alta Life Sciences
Aqua Partners LLC
Arch Venture Partners
Arix Bioscience Plc.
Astellas Innovation Management LLC
Bay City Capital LLC
BB Pureos Bioventures
Bessemer Investment Management, LLC
BioHealth Innovation, Inc.
BioScience Managers Pty Ltd.
Biotech Alliances International, Inc.
BOHE Angel Fund
Boltendahl International Partners
Brock Capital Group LLC
Brookline Capital Markets
Bryan, Garnier & Co
Capricorn Partners NV
CTI Life Sciences
Dementia Discovery Fund
DigiTx Partners, LLC
Dolby Family Ventures
Dorset Capital LLC
Eight Roads Ventures
Excellentia Global Partners
Fraser Finance LLP
Global Neurohealth Ventures
Good Health Capital LLC
GreenSky Capital, Inc.
H. Lundbeck A/S
H.C. Wainwright & Co., LLC
HBM Partners AG
Health Passion Fund
Hercules Technology Growth Capital, Inc.
High-Tech Gründerfonds Management GmbH
Inkef Capital B.V.
Ladenburg, Thalmann & Co., Inc.
Life Science Angels
LifeSci Capital, LLC
Lilly Asia Ventures
Lundbeckfonden Ventures / Lundbeckfonden Emerge
Mitsui Global Investment, Inc.
View Full List